VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

VIRAL PEPTIDES THAT INTERACT WITH HLA-A2 INHIBIT CYTO-TOXIC T-CELL ACTIVITY

Bibliografski detalji
Glavni autori:	Robbins, P, Mcmichael, A
Format:	Journal article
Izdano:	1988

Slični predmeti

Identification of T cell receptor recognition residues for a viral peptide presented by HLA B27.
od: Bowness, P, i dr.
Izdano: (1994)

Anti-viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted HLA class I/peptide complexes in SCID mice.
od: Savage, P, i dr.
Izdano: (2002)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER
od: Peto, R
Izdano: (1985)

24TH FORUM IN IMMUNOLOGY - HIV-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T - DISCUSSION
od: Koup, R, i dr.
Izdano: (1989)

HLA-peptide tetrameric complexes.
od: Ogg, G, i dr.
Izdano: (1998)

Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2.
od: Robbins, P, i dr.
Izdano: (1989)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
od: Peto, R
Izdano: (1985)

Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes.
od: Bodmer, H, i dr.
Izdano: (1989)

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.
od: Savage, P, i dr.
Izdano: (2002)

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.
od: Huet, S, i dr.
Izdano: (1990)

CHARACTERIZATION OF BLAST CELLS BY ULTRASTRUCTURAL CYTO-CHEMISTRY AND MONOCLONAL-ANTIBODIES
od: Miguel, J, i dr.
Izdano: (1983)

Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705.
od: Stewart-Jones, G, i dr.
Izdano: (2005)

A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.
od: Moots, R, i dr.
Izdano: (1991)

Immune recognition of HLA molecules downmodulates CD8 expression on cytotoxic T lymphocytes.
od: Robbins, P, i dr.
Izdano: (1991)

Dendrimers functionalized with membrane-interacting peptides for viral inhibition
od: Tarallo R, i dr.
Izdano: (2013-02-01)

IDENTIFICATION OF T-CELL RECEPTOR RECOGNITION RESIDUES FOR AN INFLUENZA-VIRUS NONAMER PEPTIDE EPITOPE PRESENTED BY HLA B27
od: Bowness, P, i dr.
Izdano: (1995)

HLA-B27-RESTRICTED PEPTIDE PRESENTATION TO CYTOTOXIC T-CELLS IN REACTIVE ARTHRITIS
od: Bowness, P, i dr.
Izdano: (1995)

Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide.
od: Kollnberger, S, i dr.
Izdano: (2007)

INTERACTION BETWEEN INFLUENZA-VIRUS AND HLA ANTIGENS
od: Hildreth, J, i dr.
Izdano: (1981)

Mutants of HLA-A2 in the analysis of its structure and function.
od: Strominger, J, i dr.
Izdano: (1989)

HLA-KIR Interactions and Immunity to Viral Infections
od: Masoud Sabouri Ghannad, i dr.
Izdano: (2014-02-01)

HLA restriction of human cytotoxic T cells.
od: Mcmichael, A
Izdano: (1980)

HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
od: Barouch, D, i dr.
Izdano: (1995)

Evidence of widespread binding of HLA class I molecules to peptides.
od: Frelinger, J, i dr.
Izdano: (1990)

Significance of the six peptide-binding pockets of HLA-A2.1 in influenza A matrix peptide-specific cytotoxic T-lymphocyte reactivity.
od: Matsui, M, i dr.
Izdano: (1994)

Cyto-Neurology in Ischemia
od: Cláudio Roque, i dr.
Izdano: (2022-07-01)

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
od: Himanshu Brahmbhatt, i dr.
Izdano: (2022-01-01)

Reconstitution of antigen presentation in HLA class I-negative cancer cells with peptide-beta2m fusion molecules.
od: Tafuro, S, i dr.
Izdano: (2001)

Specific surface area of titanium dioxide (TiO2) particles influences cyto- and photo-toxicity
od: Xiong, Sijing, i dr.
Izdano: (2013)

Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes.
od: Mcmichael, A, i dr.
Izdano: (1988)

In Vitro and In Vivo Inhibitory Activities of Selected Traditional Medicinal Plants against Toxin-Induced Cyto- and Entero- Toxicities in Cholera
od: Rajitha Charla, i dr.
Izdano: (2022-09-01)

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay
od: Walters, LC, i dr.
Izdano: (2020)

Discovery of HLA-E-presented epitopes: MHC-E/Peptide binding and t-cell recognition
od: Ruibal, P, i dr.
Izdano: (2022)

HLA-E-presented peptides as novel targets for HIV-1 therapy
od: S. Brackenridge, i dr.
Izdano: (2019-12-01)

Numerical study of the effects of hydrodynamic interactions among cells for microfluidic holographic cyto-tomography
od: Angela Vitolo, i dr.
Izdano: (2024-03-01)

Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex.
od: Bowness, P, i dr.
Izdano: (1998)

Analysis of mutant HLA-A2 molecules. Differential effects on peptide binding and CTL recognition.
od: Tussey, L, i dr.
Izdano: (1994)

Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E.
od: Braud, V, i dr.
Izdano: (1999)

Identification of a novel HLA-A2 subtype, HLA-A*0216.
od: Barouch, D, i dr.
Izdano: (1995)

Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides.
od: Goulder, P, i dr.
Izdano: (1997)